Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-08-01 to 2025-06-30
Current total value of award: $788445
Description: TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS